Waters shareholders approve combination with Becton Dickinson

Waters (WAT) shareholders voted to approve the issuance of shares of Waters common stock to shareholders of Becton Dickinson (BDX) in connection with the proposed combination of BD’s Biosciences & Diagnostic Solutions business with Waters. BD has received a favorable Private Letter Ruling from the IRS regarding matters relating to the U.S. federal income tax consequences of the transaction. Waters and BD have also received all of the required regulatory approvals. The transaction is expected to close on February 9, subject to the satisfaction of the remaining customary closing conditions. Preliminary results indicate that 99% of shares voted in favor of the issuance of shares of Waters common stock to BD shareholders.